Only One Follicle Growing During IVF: Continue, Cancel or Change Plan?

The finding can reflect a low ovarian response, asynchronous recruitment, differences in baseline reserve, medication response or cycle-specific variation. The clinician looks at serial follicle measurements and sometimes estradiol trends, along with prior records. AMH and antral follicle count help estimate likely response but do not certify egg quality or pregnancy probability for an individual. One follicle does not guarantee one egg: retrieval may produce no egg, an immature egg or an egg that does not fertilize. That uncertainty should be explicit in counselling.

Continuing stimulation toward retrieval may be considered when obtaining even one egg aligns with the patient’s goals and the clinician believes the risk-benefit balance is acceptable. Patients should understand the costs of egg retrieval, anaesthesia, embryology, potential ICSI and subsequent culture, including what happens if no usable embryo results. The decision can be different for a patient prioritizing an own-egg attempt and someone who would prefer to avoid a low-yield invasive procedure. Neither choice should be presented as a guaranteed path.

Cancelling a cycle, adjusting timing or considering another pathway are separate decisions. Converting stimulation to IUI is sometimes discussed, but only where the sperm, tubes, follicle number and overall clinical situation make IUI appropriate. It is not a generic fallback for every low-response IVF cycle. An ovulation trigger may require precise timing even when retrieval is cancelled. Never self-administer, omit or repurpose stimulation drugs without explicit instructions from the treatment team.

If the cycle is cancelled or ends without embryos, request the stimulation chart: baseline AFC, medicines, dosing changes, follicle sizes and hormone results. Discuss whether the response was expected, whether a modified protocol has a plausible rationale, and whether repeating the same approach makes sense. Ask which tests genuinely affect a future decision. More medication is not always better for low reserve. Consider treatment burden, time, costs and the emotional impact of repeated cycles as part of informed consent.

HomeIVF describes doctor-led fertility care supported by remote reviews and selected home services rather than a promise that IVF can occur in a living room. In Low ovarian response, previous reports may be reviewed without another unnecessary appointment, and some blood collection or prescribed injection support may be possible when the specific address is serviceable. Availability must be verified, not inferred. Ultrasound when required, procedural monitoring, egg retrieval, laboratory fertilization and embryo transfer still occur at appropriate facilities. Patients should retain a named clinical contact and know which symptoms require prompt physical assessment. Coordination is most valuable when it removes duplication while keeping every medically necessary step intact.

A useful review for Low ovarian response begins with the actual records, not a broad promise of success. Ask which findings are certain, which are provisional and what information is still missing. Request the medical reason for any proposed add-on or repeated test, along with the potential downside of delaying or proceeding. Confirm the locations of required imaging, laboratory work and procedures. Ask for a complete quote and a plan for abnormal findings or urgent symptoms. Patients should have time to consider an option without being pressured by artificial discounts or unsupported success claims.

What to document before the next review

For Low ovarian response, save the complete dated reports, not just highlighted numbers or phone screenshots. Note the actual medications taken, important symptoms, previous procedures and what the last clinician advised. Where a partner’s fertility assessment is relevant, include it too. Ask the medical team which result is decisive and which finding remains uncertain. This makes a second opinion more focused and reduces the chance of paying for repeated tests that do not change the decision. If new symptoms arise between scheduled visits, inform the treating team rather than relying on an old interpretation.

Seeking another specialist’s view does not necessarily mean changing clinics. It can clarify whether the existing diagnosis is secure, why a particular medication or test was suggested and how different options compare. Share the same primary records with both clinicians and ask them to identify the precise points of agreement or disagreement. Decisions are easier when information is documented rather than repeated from memory. A responsible team should welcome questions about risks, uncertainty and the location of essential procedures.